$SLP

Monteverde & Associates PC says it is investigating merger-related claims involving Pulmatrix (PULM) and Eos SenolyTix, Simulations Plus (SLP) and Altaris affiliates, Olin (OLN) and Huntsman (HUN). It cites expected ownership and deal terms, including $18.50 per SLP share cash and Huntsman receiving 0.5476 OLN shares. Shareholder votes are scheduled for Aug. 25, 2026.

U.S. stock futures were mixed as Dow Jones rose while Nasdaq 100 and S&P 500 fell. Treasury yields were 10-year 4.54% and 2-year 4.17%, with CME FedWatch pricing a 79.1% chance the Fed holds rates in July. Company moves: WD-40 up 14.86% on Q3 results; Equipmentshare up 17.75% on 2026 guidance and a $500M buyback; Netflix up 0.54% on reported strategy review; Simulations Plus down 0.65% despite upbeat Q3 earnings. Bitcoin rose 2.21% to $64,172.

Simulations Plus, Inc. (SLP) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 slp-2026531xexx991x263.htm EX-99.1 Document Exhibit 99.1 Simulations Plus Reports Third Quarter Fiscal 2026 Financial Results RESEARCH TRIANGLE PARK, NC, July 9, 2026 – Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus” or the “Company”), a global leader in model-

Sylvania Platinum (LSE: SLP) processes chrome miner Samancor’s PGM-rich waste and, via a JV with Limberg Mining (Thaba), also retains PGMs and chrome from mine waste. The article cites a 61% rise in adjusted cash profit in the March quarter and FY2026 production guidance of 90,000 to 93,000 oz. It highlights a dividend policy of at least 40% of free cash flow and RBC forecasts distributions rising from 2.75p (2025) to 14.6p (FY2027).

Simulations Plus, Inc. (SLP) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-2.1 2 ex21-mergeragreement1086.htm EX-2.1 ex21-mergeragreement1086 Exhibit 2.1 AGREEMENT AND PLAN OF MERGER dated as of June 15, 2026 among SIMULATIONS PLUS, INC., SP EVOLUTION HOLDCO II, LLC and SP EVOLUTION BIDCO II, LLC AGREEMENT AND PLAN OF MERGER AGREEMENT AND PLAN OF MER

Altaris plans to acquire Simulations Plus in an all-cash transaction valued at $375 million, according to the article. The deal would bring Simulations Plus under Altaris’ ownership, which may affect investors’ exposure to the companies’ respective operations and future financial outlook.

DiBella John Anthony II (Chief Revenue Officer) sold 1,000 shares of Simulations Plus, Inc. (SLP) at $16.50 on 2026-06-03 under a Rule 10b5-1 trading plan.

RBC Capital Markets initiated coverage of Sylvania Platinum (AIM:SLP) with an Outperform rating and a 175p target, implying 90% upside from 92p. RBC says the shares trade at 0.6x net asset value and 20% free cash flow yield on 2027 estimates, reflecting “mispricing.” It cites a potential production cliff after 2030 as waste feed runs down, but expects the Thaba joint venture to add 26% to production and forecasts average dividend yields of 14.4% over three years.

WOLTOSZ WALTER S sold 15,000 shares of Simulations Plus, Inc. (SLP) at $17.43 ($0.26M total) on 2026-06-01 under a Rule 10b5-1 trading plan.

Simulations Plus, Lonza, and the U.S. FDA are collaborating on a funded research initiative to develop and validate a mechanistic, predictive framework for amorphous solid dispersion (ASD) drug products. This partnership aims to integrate advanced in vitro systems with mechanistic modeling to improve predictions of in vivo performance, reduce the need for extensive clinical bioequivalence studies, and support regulatory decision-making for complex oral formulations. The goal is to accelerate the development of high-impact therapies by creating more efficient and scientifically rigorous pathways.